COMMUNIQUÉS West-GlobeNewswire

Shire plc : Director/PDMR Shareholding
29/08/2017
Director/PDMR Shareholding August 29, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transaction by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Apricus Biosciences Files NDA Resubmission for Vitaros(TM)
29/08/2017
Approval Decision Expected in First Quarter 2018 SAN DIEGO, Aug. 29, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and [...]
Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units
29/08/2017
Reference is made to the stock exchange notice of 18 August 2017 regarding the board of directors' resolution to increase the share capital in Targovax ASA (the "Company") in connection with the exercise of employee [...]
NxSE Forum 2017, Reunion Island (Indian Ocean), annual meeting of the African Tech
29/08/2017
On October 3, 4 and 5, the second NxSE edition (pronounce Nexi), the « International Digital Shift Forum - Indian Ocean & Africa » will be held in Reunion Island, a French department located in the Indian Ocean. [...]
Herantis Pharma Plc's half year financial report January 1 - June 30, 2017 (unaudited)
29/08/2017
Herantis Pharma Plc Company release August 29, 2017 at 9:00am Drug development progresses towards randomized trials Herantis Pharma Plc's half year financial report January 1 - June 30, 2017 (unaudited) Highlights in [...]
PCI Biotech: First half year 2017 report and presentation
29/08/2017
Oslo, 29 August 2017 - Please find enclosed the financial report and presentation for second quarter and first half year 2017. PCI Biotech reported important progress for the fima Chem programme during 1H 2017, with [...]
DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut
29/08/2017
Press Release Montrouge, France, August 29, 2017 DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut 93% of patients completing PEPITES opted to enroll in follow-up study [...]
DBV Technologies annonce la fin du recrutement de l'étude d'extension de phase III de Viaskin Peanut
29/08/2017
Communiqué de presse Montrouge, France, le 29 août 2017 DBV Technologies annonce la fin du recrutement de l'étude d'extension de phase III de Viaskin Peanut 93% des patients ayant terminé l'étude PEPITES ont choisi de [...]
Unique binding mode of PBD-C06 to pGlu-Abeta peptides identified
29/08/2017
Unique binding mode of PBD-C06 to pGlu-Abeta peptides identified Probiodrug publishes mechanism of target binding for its lead anti-pGlu-Abeta monoclonal antibody PBD-C06 HALLE (SAALE), Germany, 29 August 2017 - [...]
Solon Eiendom ASA : Q2 2017 All-time high sales value
29/08/2017
(Oslo, Norway, 29 August 2017) Solon Eiendom ASA (OSE:SOLON) is presenting the Q2 2017 report at 08.30 am CET at Sparebank 1 Markets, Olav Vs gate 5 in Oslo. The quarterly presentation materials is enclosed and will be [...]
Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant
28/08/2017
DANVERS, Mass., Aug. 28, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today that it has accepted the resignation of its [...]
ProMIS Neurosciences Completes Second Closing of Private Placement
28/08/2017
TORONTO, Aug. 28, 2017 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. ("ProMIS" or the "Company") (TSX:PMN) (OTCPK:ARFX.F) (DB:23J) is pleased to announce that, further to its news releases dated July 20, 2017, August 2 [...]
Ossur Hf : Transactions in relation to share buyback program
28/08/2017
Announcement from Össur hf. No. 64/2017 Reykjavík, 28 August 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
Sanofi : Disclosure of trading in own shares
28/08/2017
Reporting EN This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, [...]
Sanofi : Déclaration des transactions sur actions propres
28/08/2017
Reporting FR This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, [...]
Novo Nordisk A/S - Share repurchase programme
28/08/2017
Bagsværd, Denmark, 28 August 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Interim Data on MobiusHD Presented at the European Society of Cardiology Shows Promise in the Treatment of Resistant Hypertension
28/08/2017
MOUNTAIN VIEW, Calif., Aug. 28, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announced interim [...]
Shire plc : MYDAYIS(TM) (mixed salts of a single-entity amphetamine product), Shire's New Once-Daily ADHD Treatment, Now Available in the U.S.
28/08/2017
For U.S. Audiences Only MYDAYIS(TM) (mixed salts of a single-entity amphetamine product), Shire's New Once-Daily ADHD Treatment, Now Available in the U.S. Mydayis, which is now available in the U.S., demonstrated [...]
Medtronic Plans for Renal Denervation Pivotal Trial After New Study Shows Significant Blood Pressure Reductions
28/08/2017
Published Simultaneously in The Lancet , the Late-Breaking SPYRAL HTN-OFF MED Study at ESC Successfully Isolates RDN Treatment Effect to Show Compelling Efficacy and Safety of Hypertension Procedure DUBLIN and BARCELONA [...]

Pages